Distinguishing Pathovars from Nonpathovars: Escherichia coli.
Riley LW.
Microbiol Spectr. 2020 Dec;8(4):10.1128/microbiolspec.ame-0014-2020. doi: 10.1128/microbiolspec.AME-0014-2020.
Escherichia coli--an overview.
Cooke EM.
J Hyg (Lond). 1985 Dec;95(3):523-30. doi: 10.1017/s022217240006065x.
Proteomics of septicemic Escherichia coli.
Otto A, Biran D, Sura T, Becher D, Ron EZ.
Proteomics Clin Appl. 2016 Oct;10(9-10):1020-1024. doi: 10.1002/prca.201600049.
Escherichia coli sequence type 131: epidemiology and challenges in treatment.
Qureshi ZA, Doi Y.
Expert Rev Anti Infect Ther. 2014 May;12(5):597-609. doi: 10.1586/14787210.2014.899901. Epub 2014 Apr 2.
Escherichia coli bacteraemia.
OWEN T, SPAULDING WB.
Can Med Assoc J. 1956 Dec 15;75(12):1020-4.
What makes Escherichia coli pathogenic?
Siitonen A.
Ann Med. 1994 Aug;26(4):229-31. doi: 10.3109/07853899409147895.
Clonality and virulence traits of Escherichia coli associated with haemorrhagic septicaemia in turkeys.
Olsen RH, Chadfield MS, Christensen JP, Scheutz F, Christensen H, Bisgaard M.
Avian Pathol. 2011 Dec;40(6):587-95. doi: 10.1080/03079457.2011.618942.
Association of microbiological factors with mortality in Escherichia coli bacteraemia presenting with sepsis/septic shock: a prospective cohort study.
Maldonado N, López-Hernández I, López-Cortés LE, Martínez Pérez-Crespo PM, Retamar-Gentil P, García-Montaner A, De la Rosa Riestra S, Sousa-Domínguez A, Goikoetxea J, Pulido-Navazo Á, Del Valle Ortíz M, Natera-Kindelán C, Jover-Sáenz A, Arco-Jiménez AD, Armiñanzas-Castillo C, Aller-García AI, Fernández-Suárez J, Marrodán-Ciordia T, Boix-Palop L, Smithson-Amat A, Reguera-Iglesias JM, Galán-Sánchez F, Bahamonde A, Sánchez-Calvo JM, Gea-Lázaro I, Pérez-Camacho I, Reyes-Bertos A, Becerril-Carral B, Pascual Á, Rodríguez-Baño J; PROBAC REIPI/GEIRAS-SEIMC/SAMICEI Group.
Clin Microbiol Infect. 2024 Aug;30(8):1035-1041. doi: 10.1016/j.cmi.2024.04.001. Epub 2024 Apr 8.
Tigecycline susceptibility in Klebsiella pneumoniae and Escherichia coli causing neonatal septicaemia (2007-10) and role of an efflux pump in tigecycline non-susceptibility.
Roy S, Datta S, Viswanathan R, Singh AK, Basu S.
J Antimicrob Chemother. 2013 May;68(5):1036-42. doi: 10.1093/jac/dks535. Epub 2013 Jan 18.
Occurrence and characteristics of CS31A antigen-producing Escherichia coli in calves with diarrhoea and septicaemia in Argentina.
Mercado EC, Rodríguez SM, D'Antuono AL, Cipolla AL, Elizondo AM, Rossetti CA, Malena R, Méndez MA.
J Vet Med B Infect Dis Vet Public Health. 2003 Feb;50(1):8-13. doi: 10.1046/j.1439-0450.2003.00610.x.
